Search

everythinglearnresearchcommunity

for

Search:↓

Cyclophosphamide often causes gastrointestinal issues, hair loss, and low blood cell counts in Chinese patients with autoimmune diseases.

DHL-HisZnNa may help reduce hair loss from chemotherapy, but more research is needed.

A lotion with natural extracts significantly sped up hair growth in women with hair loss from chemotherapy.

Persistent radiation-induced hair loss is dose-dependent, and treatments like topical minoxidil can be effective.

Dutasteride is more effective than finasteride for long-term hair growth in men with androgenic alopecia.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Hair loss from hormone therapy in breast cancer patients can be improved with minoxidil treatment.

Photobiomodulation therapy helps manage cancer treatment side effects but needs more research for optimization.

The medications 5α-reductase inhibitors and spironolactone are generally safe for breast cancer patients on endocrine therapies and do not significantly increase breast cancer risk.

Itraconazole is potentially effective for treating invasive aspergillosis, but more research is needed.

Mitoxantrone is effective for treating acute leukemia, especially in older patients, with a lower risk of heart damage.

Chemotherapy improved a girl's painful foot condition linked to pachyonychia congenita.

Telogen Effluvium is a hair loss condition where treatment involves identifying and managing its triggers.

Skin conditions in multiple myeloma patients vary with the timing of bone marrow transplants.

Non-coding RNAs could help detect and treat radiation damage.

Anti-cancer treatments can cause reversible hair loss, skin sensitivity, pigmentation changes, nail damage, and skin reactions, with a need for more research on managing these side effects.

New treatments for psoriasis have improved effectiveness and may reduce long-term side effects when combined with standard therapies.

Radiation therapy with chemotherapy can cause severe, long-lasting hair loss.

Chemotherapy with docetaxel can cause painful nail and skin side effects that may lead to stopping treatment.

Early recognition and management of skin side effects from new cancer therapies can prevent treatment delays.

Scalp cooling can prevent chemotherapy-induced hair loss, and certain treatments can speed up hair regrowth, but more research is needed for better treatments.

Cyclophosphamide helped 59.4% of children with steroid-resistant nephrotic syndrome but caused side effects in 40.6%.

Hair usually grows back 1-3 months after treatment for anagen effluvium, and children with Loose Anagen Hair Syndrome often improve by adolescence.

Iron and zinc levels in hair are not linked to hair loss from chemotherapy.

Scalp cooling is an effective way to prevent hair loss from chemotherapy.

YH0618 helps reduce chemotherapy-induced hair loss by targeting specific proteins and pathways.

Skin reactions from cancer treatments might predict how well the treatments work.

Some breast cancer patients on hormonal therapy may develop male or female pattern hair loss, which can sometimes be improved with topical treatments.

Immunosuppressive therapy helps manage autoimmune diseases but carries risks like infection and potential for malignancy.

LED light therapy is effective for skin and hair treatments but requires careful use to minimize risks.